Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial and protozoal toxins are substances produced by microorganisms that cause damage to host tissues and are central to the pathogenesis of various infectious diseases (StatPearls, 2023). Bacterial toxins are broadly categorized into exotoxins, which are actively secreted proteins, and endotoxins, which are structural components of the bacterial cell wall like lipopolysaccharide (StatPearls, 2023). These molecules exert their effects through diverse mechanisms, such as forming pores in host membranes, enzymatically modifying host proteins via ADP-ribosylation, or overstimulating the immune system as superantigens (Nature Reviews Microbiology, 2010). Protozoal toxins, while less common, include factors like the pore-forming proteins of Entamoeba histolytica or the pro-inflammatory glycosylphosphatidylinositol anchors of Plasmodium species (PubMed, 2001). In therapeutic contexts, these toxins are considered targets for passive immunization strategies, where exogenous antibodies or antitoxins are administered to neutralize the toxin's activity (Journal of Clinical Investigation, 2017). Examples of such therapies include bezlotoxumab for Clostridioides difficile infection and raxibacumab for inhalational anthrax (FDA, 2016). Targeting these toxins is often critical in diseases where the toxin, rather than the organism itself, is the primary driver of morbidity and mortality (Clinical Microbiology Reviews, 2019).
Neutralization of toxin activity by preventing binding to host cell receptors or inhibiting enzymatic activity.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial and protozoal toxins.